¿ 3-Dimensional Pharmaceuticals Inc., of Exton, Pa., appointed to its scientific advisory board Stephen Benkovic, an Evan Pugh Professor at Penn State University.

¿ Advanced Cell Technology Inc., of Worcester, Mass., named Robert Lanza senior director of tissue engineering and transplant medicine.

¿ Angstrom Pharmaceuticals Inc., of San Diego, appointed to its scientific board Webster Cavenee, director of the Ludwig Institute for Cancer Research and a professor of medicine at the University of California San Diego; Ronald Goldfarb, professor and chairman of the department of molecular biology and immunology and director of the Institute for Cancer Research at the University of North Texas Health Science Center in Fort Worth; and Bruce Zetter, of Harvard Medical School and Children¿s Hospital in Boston.

¿ Avigen Inc., of Alameda, Calif., appointed Alan McClelland vice president, research and development.

¿ Axonyx Inc., of New York, retained Norman Lavy as senior consultant and adviser in pharmaceutical research, medical and regulatory affairs.

¿ Cephalon Inc., of West Chester, Pa., promoted George McCormick to vice president, drug safety and disposition; Randy Bradway, to senior director, logistics, distribution and trade relations; and Robert Urban, to senior director, technical operations.

¿ Cypress Bioscience Inc., of San Diego, promoted Judith Doe to vice president of marketing and sales.

¿ Cypros Pharmaceutical Corp., of Carlsbad, Calif., named John Lee vice president, sales and marketing.

¿ Delsys Pharmaceutical Corp., of Princeton, N.J., appointed Ashok Katdare senior director of formulation.

¿ Desmos Inc., of San Diego, named to its scientific board Mina Bissell, director of the life sciences division of the Lawrence Berkeley National Laboratory, and Zena Werb, professor of anatomy at the University of California San Francisco School of Medicine.

¿ Emisphere Technologies Inc., of Tarrytown, N.Y., named Charles Abdalian chief financial officer and Steven Dinh vice president of research.

¿ GeneTrace Systems Inc., of Alameda, Calif., appointed to its board of directors James Glavin, chairman of The Immune Response Corp.

¿ Geron Corp., of Menlo Park, Calif., named Amy Tsui Collings vice president, intellectual properties.

¿ IDM, of Paris, named Jean-Marie Dupuy vice president of medical affairs.

¿ InKine Pharmaceutical Co. Inc., of Blue Bell, Pa., ap pointed Barbara Nagle vice president of clinical operations.

¿ IntraBiotics Pharmaceuticals Inc., of Mountain View, Calif., appointed Charlotte Rogers senior director, corporate development.